IRISanRaf

CATURANO, ALFREDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.128
NA - Nord America 3.076
SA - Sud America 1.264
EU - Europa 844
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 75
OC - Oceania 15
Totale 9.564
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.919
SG - Singapore 2.639
BR - Brasile 956
IT - Italia 593
VN - Vietnam 539
CN - Cina 313
BD - Bangladesh 287
AR - Argentina 126
HK - Hong Kong 114
CA - Canada 66
EC - Ecuador 65
ID - Indonesia 61
NL - Olanda 56
MX - Messico 46
PK - Pakistan 43
CO - Colombia 37
GB - Regno Unito 34
DE - Germania 31
IN - India 29
ZA - Sudafrica 28
RU - Federazione Russa 26
PY - Paraguay 24
CL - Cile 20
FR - Francia 18
IQ - Iraq 15
IL - Israele 14
PL - Polonia 14
UA - Ucraina 14
PE - Perù 13
VE - Venezuela 11
CR - Costa Rica 10
MA - Marocco 10
TR - Turchia 10
AU - Australia 9
IE - Irlanda 9
SA - Arabia Saudita 9
AT - Austria 7
EG - Egitto 7
TN - Tunisia 7
ES - Italia 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
UZ - Uzbekistan 6
AM - Armenia 5
BO - Bolivia 5
HN - Honduras 5
JM - Giamaica 5
NI - Nicaragua 5
NP - Nepal 5
AL - Albania 4
GT - Guatemala 4
JO - Giordania 4
JP - Giappone 4
KZ - Kazakistan 4
MY - Malesia 4
TW - Taiwan 4
AO - Angola 3
AZ - Azerbaigian 3
HR - Croazia 3
KR - Corea 3
PR - Porto Rico 3
PT - Portogallo 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BW - Botswana 2
BY - Bielorussia 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
FI - Finlandia 2
KE - Kenya 2
MD - Moldavia 2
MU - Mauritius 2
PH - Filippine 2
QA - Qatar 2
SC - Seychelles 2
SE - Svezia 2
SN - Senegal 2
AW - Aruba 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
ET - Etiopia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KH - Cambogia 1
Totale 9.391
Salva come PNG Salva come JPEG
Città #
Dallas 964
San Jose 425
Ashburn 316
Council Bluffs 305
Rome 279
Singapore 229
Ho Chi Minh City 193
Phoenix 140
Beijing 128
Hanoi 112
Hong Kong 111
São Paulo 83
Santa Clara 53
Amsterdam 44
New York 42
Los Angeles 41
Milan 34
Naples 33
Chicago 30
Islamabad 30
Rio de Janeiro 27
Mexico City 26
Buffalo 25
Haiphong 25
Quito 22
Guayaquil 21
Biên Hòa 16
Brasília 16
Munich 16
Manaus 15
Thái Bình 15
Da Nang 14
Hải Dương 14
Bogotá 13
Guarulhos 13
Johannesburg 13
Curitiba 12
Montreal 12
Can Tho 11
Netanya 11
Porto Alegre 11
Princeton 11
Asunción 10
Belo Horizonte 10
Brooklyn 10
Bắc Ninh 10
Campinas 10
Dhaka 10
Duque de Caxias 10
Florence 10
Jakarta 10
Ninh Bình 10
Orem 10
Thái Nguyên 10
Atlanta 9
Boardman 9
Buenos Aires 9
Frankfurt am Main 9
Miami 9
Salvador 9
Abbeville 8
Bari 8
Bắc Giang 8
Caxias do Sul 8
Fortaleza 8
Goiânia 8
Maricá 8
Quảng Ngãi 8
Recife 8
Santiago 8
Santo André 8
Seattle 8
Warsaw 8
Bauru 7
Catania 7
Dublin 7
Joinville 7
Lima 7
Palermo 7
Petrópolis 7
San José 7
São José 7
Toronto 7
Bandung 6
Boston 6
Cabo Frio 6
Cape Town 6
Charlotte 6
Chennai 6
Ha Long 6
Hortolândia 6
Sorocaba 6
Sumaré 6
Suzano 6
Tashkent 6
Turin 6
Baghdad 5
Bologna 5
Caruaru 5
Casablanca 5
Totale 4.397
Salva come PNG Salva come JPEG
Nome #
Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin 319
Advances in Nanomedicine for Precision Insulin Delivery 254
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 253
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 250
The impact of incidental hepatocellular carcinoma in liver transplantation: A growing concern 242
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 242
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 242
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 241
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 235
Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects? 228
Metabolic Dysfunction-Associated Steatotic Liver Disease in Klinefelter Syndrome: High Prevalence Uncovers an Unmet Need 226
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 224
SGLT2 Inhibitors and GLP-1 Receptor Agonists in PAD: A State-of-the-Art Review 202
Cardiovascular and Metabolic Disease: New Treatment and Future Directions—The 3rd Edition 181
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 170
Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 149
Bridging ADHD and Metabolic Disorders: Insights into Shared Mechanisms and Clinical Implications 108
Risk Stratification For and Use of DOAC Therapies for Stroke Prevention in Patient with Atrial Fibrillation 108
Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study 93
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 84
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 83
Sarcopenic obesity and weight loss-induced muscle mass loss 83
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 81
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 77
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 76
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 76
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial 75
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 74
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 74
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 68
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 65
Advancements in Cardiovascular and Antidiabetic Drug Therapy 64
Aspirin in a diabetic retinopathy setting: Insights from NO BLIND study 64
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 63
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 2.0 63
Cardiovascular and Metabolic Disease: New Treatment and Future Directions 61
Improvement of Global Longitudinal Strain and Myocardial Work in Type 2 Diabetes Patients on Sodium-Glucose Cotransporter 2 Inhibitors Therapy 60
Reply to Saeed et al. Comment on “Rinaldi et al. Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study. Viruses 2025, 17, 251” 60
Atrial fibrillation and stroke. A review on the use of vitamin K antagonists and novel oral anticoagulants 60
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 57
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 57
Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study 57
Oral Anticoagulation for Atrial Fibrillation in Octogenarians Across the Renal Function Spectrum 56
Commentary on Antithrombotic Effect of Protopanaxatriol Saponins from Panax notoginseng Using Zebrafish Model 55
Optimizing Body Composition During Weight Loss: The Role of Amino Acid Supplementation 55
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 55
Antioxidant and Antidiabetic Potential of the Antarctic Lichen Gondwania regalis Ethanolic Extract: Metabolomic Profile and In Vitro and In Silico Evaluation 55
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 55
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 54
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 54
Insulin resistance and cancer: molecular links and clinical perspectives 54
Bivalirudin Use for Primary Percutaneous Coronary Intervention on Long-Term Mortality 53
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 52
Role of albuminuria in detecting cardio-renal risk and outcome in diabetic subjects 52
Right ventricular electrocardiographic abnormalities among hospitalized COVID-19 patients: Simple marker of worst clinical outcome 52
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 52
Oxidative Stress in Diabetic Cardiomyopathy: Molecular Mechanisms and Emerging Therapeutic Targets 52
Editorial on: Canagliflozin Mediates Mitophagy Through the AMPK/PINK1/PARKIN Pathway to Alleviate Isoprenaline-Induced Cardiac Remodeling 51
Predictors of Plasma Levels of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation in Need of Elective Cardiac Procedures 51
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 51
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 51
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 51
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 51
Clinical performance of subcutaneous vs. transvenous implantable defibrillator in patients with ischemic cardiomyopathy: data from Monaldi Rhythm Registry 51
The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy 50
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 50
Rethinking the Diabetes–Cardiovascular Disease Continuum: Toward Integrated Care 50
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 50
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights 50
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 50
Clinical Utilization and Performance of Bempedoic Acid in an Italian Real-World Setting: Insight from Campania Region 49
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 49
The prognostic role of interatrial block among COVID-19 patients hospitalized in medicine wards 49
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 49
HCC and molecular targeting therapies: Back to the future 49
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 48
Anti-Inflammatory and Anticancer Effects of Anticoagulant Therapy in Patients with Malignancy 48
Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 48
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 47
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study 47
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 46
Impact of sglt2 inhibitors on heart failure: From pathophysiology to clinical effects 46
HAND GRIP STRENGTH EVALUATION IN RHEUMATOLOGIC DISEASES 45
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 45
Non-alcoholic fatty liver disease: From pathogenesis to clinical impact 44
When the dual-chamber pacing system is the optimal choice for Brugada patients in need of implantable cardiac defibrillator 44
Impact of Empagliflozin as add-on to Metformin vs Metformin continuation on MASLD Progression in Type 2 Diabetes: The IMAGIN Study 43
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 43
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 42
Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review 42
Cardiovascular and Metabolic Disease: New Treatments and Future Directions 2.0 42
Post-fracture thromboprophylaxis: is it time for a change? 42
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 42
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 42
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 41
Cardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development 41
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 40
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 39
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 39
Comment on: Prevalence of micro and macro vascular complications and their risk factors in type 2 diabetes in saudi arabian population: An analysis from shis 39
Totale 8.342
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.593 0 0 0 0 0 0 4 18 2 227 1.264 1.078
2025/20265.663 192 361 1.381 1.267 239 306 378 292 348 315 289 295
2026/20271.308 65 411 554 278 0 0 0 0 0 0 0 0
Totale 9.564